Bio-Thera Solutions Ltd (688177) — Cash Flow-to-Debt Ratio
Bio-Thera Solutions Ltd (688177) has a Cash Flow-to-Debt Ratio of -0.08x as of June 2023, meaning its operating cash flow of CN¥-72.53 Million could theoretically repay 0% of its total liabilities (CN¥929.59 Million) in one year. See free cash flow generation of Bio-Thera Solutions Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Bio-Thera Solutions Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Bio-Thera Solutions Ltd across 10 annual periods. Also explore how fast is Bio-Thera Solutions Ltd growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Bio-Thera Solutions Ltd (2016–2025)
Year-by-year debt coverage analysis for Bio-Thera Solutions Ltd. For market capitalisation and broader financial context, see market cap of Bio-Thera Solutions Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.04x | CN¥-82.11 Million | CN¥1.91 Billion | ▼ -15.6% |
| 2024 | -0.04x | CN¥-55.65 Million | CN¥1.50 Billion | ▲ +91.3% |
| 2023 | -0.43x | CN¥-460.87 Million | CN¥1.07 Billion | ▲ +40.5% |
| 2022 | -0.72x | CN¥-412.82 Million | CN¥572.48 Million | ▼ -261.8% |
| 2021 | 0.45x | CN¥236.27 Million | CN¥530.27 Million | ▲ +148.2% |
| 2020 | -0.92x | CN¥-358.04 Million | CN¥387.56 Million | ▲ +40.7% |
| 2019 | -1.56x | CN¥-597.98 Million | CN¥383.68 Million | ▲ +35.3% |
| 2018 | -2.41x | CN¥-528.25 Million | CN¥219.44 Million | ▼ -176.0% |
| 2017 | -0.87x | CN¥-236.68 Million | CN¥271.39 Million | ▼ -30.5% |
| 2016 | -0.67x | CN¥-116.18 Million | CN¥173.86 Million | — |